Skip to main content
Erschienen in: Der Diabetologe 3/2018

02.05.2018 | Tuberkulose | Leitthema

Diabetes und Tuberkulose

Eine kurze Übersicht

verfasst von: Dr. B. Lange, A. Bockey, J. L. Z. Nyirenda, D. Wagner

Erschienen in: Die Diabetologie | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Hintergrund

Tuberkulose ist weiterhin die Infektionskrankheit, an welcher weltweit die meisten Menschen versterben.

Ziel des Beitrags

Die aktuelle Literatur zur Assoziation von Diabetes und Tuberkulose wird beschrieben, und Fragen des klinischen Managements bei Patienten mit beiden Diagnosen werden diskutiert.

Ansteckungsgefahr

Das Risiko, an einer Tuberkulose zu erkranken, ist bei Patienten mit Diabetes im Vergleich zur nicht an dieser Stoffwechselerkrankung leidenden Bevölkerung verdreifacht.

Therapie von an Tuberkulose erkrankten Diabetespatienten

Die Behandlungsergebnisse bezüglich der Tuberkulose sind bei Patienten mit vs. ohne Diabetes schlechter, und sowohl die Therapie der Tuberkulose als auch die des Diabetes werden durch Medikamenteninteraktionen erschwert.
Literatur
1.
Zurück zum Zitat World Health Organization (2017) Global Tuberculosis Report 2017. World Health Organization, Genf World Health Organization (2017) Global Tuberculosis Report 2017. World Health Organization, Genf
2.
Zurück zum Zitat World Health Organization (2014) End TB Strategy. World Health Organization, Genf World Health Organization (2014) End TB Strategy. World Health Organization, Genf
3.
Zurück zum Zitat Grillo VJ (1933) The type and distribution of pathology in pulmonary tuberculosis associated with diabetes mellitus. Yale J Biol Med 5(6):559–572PubMedPubMedCentral Grillo VJ (1933) The type and distribution of pathology in pulmonary tuberculosis associated with diabetes mellitus. Yale J Biol Med 5(6):559–572PubMedPubMedCentral
5.
Zurück zum Zitat Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. Plos Med 5(7):e152CrossRefPubMedPubMedCentral Jeon CY, Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. Plos Med 5(7):e152CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ (2017) Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS ONE 12(11):e187967CrossRefPubMedPubMedCentral Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ (2017) Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PLoS ONE 12(11):e187967CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, Gomez-Perez FJ, Valdespino-Gomez JL, Olaiz-Fernandez G et al (2004) Tuberculosis and diabetes in southern Mexico. Diabetes Care 27(7):1584–1590CrossRefPubMed Ponce-De-Leon A, Garcia-Garcia Md Mde L, Garcia-Sancho MC, Gomez-Perez FJ, Valdespino-Gomez JL, Olaiz-Fernandez G et al (2004) Tuberculosis and diabetes in southern Mexico. Diabetes Care 27(7):1584–1590CrossRefPubMed
8.
Zurück zum Zitat Lee MR, Huang YP, Kuo YT, Luo CH, Shih YJ, Shu CC et al (2017) Diabetes mellitus and latent tuberculosis infection: a systemic review and Metaanalysis. Clin Infect Dis 64(6):719–727PubMed Lee MR, Huang YP, Kuo YT, Luo CH, Shih YJ, Shu CC et al (2017) Diabetes mellitus and latent tuberculosis infection: a systemic review and Metaanalysis. Clin Infect Dis 64(6):719–727PubMed
9.
Zurück zum Zitat Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K et al (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 9:81CrossRefPubMedPubMedCentral Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lonnroth K et al (2011) The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med 9:81CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Tegegne BS, Habtewold TD, Mengesha MM, Burgerhof JG (2017) Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis. Syst Rev 6(1):6CrossRefPubMedPubMedCentral Tegegne BS, Habtewold TD, Mengesha MM, Burgerhof JG (2017) Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis. Syst Rev 6(1):6CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Odone A, Houben RM, White RG, Lonnroth K (2014) The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets. Lancet Diabetes Endocrinol 2(9):754–764CrossRefPubMed Odone A, Houben RM, White RG, Lonnroth K (2014) The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets. Lancet Diabetes Endocrinol 2(9):754–764CrossRefPubMed
12.
Zurück zum Zitat Pan SC, Ku CC, Kao D, Ezzati M, Fang CT, Lin HH (2015) Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol 3(5):323–330CrossRefPubMed Pan SC, Ku CC, Kao D, Ezzati M, Fang CT, Lin HH (2015) Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study. Lancet Diabetes Endocrinol 3(5):323–330CrossRefPubMed
14.
Zurück zum Zitat Restrepo BI, Schlesinger LS (2013) Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis (Edinb) 93(Suppl):S10–S4CrossRef Restrepo BI, Schlesinger LS (2013) Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis (Edinb) 93(Suppl):S10–S4CrossRef
15.
Zurück zum Zitat Handel AE, Ramagopalan SV (2010) Tuberculosis and diabetes mellitus: is vitamin D the missing link? Lancet Infect Dis 10(9):596CrossRefPubMed Handel AE, Ramagopalan SV (2010) Tuberculosis and diabetes mellitus: is vitamin D the missing link? Lancet Infect Dis 10(9):596CrossRefPubMed
16.
Zurück zum Zitat Wang Q, Ma A, Han X, Zhang H, Zhao S, Liang H et al (2017) Is low serum 25-hydroxyvitamin D a possible link between pulmonary tuberculosis and type 2 diabetes? Asia Pac J Clin Nutr 26(2):241–246PubMed Wang Q, Ma A, Han X, Zhang H, Zhao S, Liang H et al (2017) Is low serum 25-hydroxyvitamin D a possible link between pulmonary tuberculosis and type 2 diabetes? Asia Pac J Clin Nutr 26(2):241–246PubMed
17.
Zurück zum Zitat Liao T‑L, Lin C‑F, Chen Y‑M, Liu H‑J, Chen D‑Y (2016) Risk factors and outcomes of Nontuberculous Mycobacterial disease among rheumatoid arthritis patients: a case-control study in a TB endemic area. Sci Rep 6:29443CrossRefPubMedPubMedCentral Liao T‑L, Lin C‑F, Chen Y‑M, Liu H‑J, Chen D‑Y (2016) Risk factors and outcomes of Nontuberculous Mycobacterial disease among rheumatoid arthritis patients: a case-control study in a TB endemic area. Sci Rep 6:29443CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Alim MA, Sikder S, Bridson TL, Rush CM, Govan BL, Ketheesan N (2017) Anti-mycobacterial function of macrophages is impaired in a diet induced model of type 2 diabetes. Tuberculosis (Edinb) 102:47–54CrossRef Alim MA, Sikder S, Bridson TL, Rush CM, Govan BL, Ketheesan N (2017) Anti-mycobacterial function of macrophages is impaired in a diet induced model of type 2 diabetes. Tuberculosis (Edinb) 102:47–54CrossRef
19.
Zurück zum Zitat WHO (2011) Collaborative framework for care and control of tuberculosis and diabetes. WHO guidelines approved by the guidelines review committee. WHO, Genf WHO (2011) Collaborative framework for care and control of tuberculosis and diabetes. WHO guidelines approved by the guidelines review committee. WHO, Genf
20.
Zurück zum Zitat Maurice J (2011) WHO framework targets tuberculosis-diabetes link. Lancet 378(9798):1209–1210CrossRefPubMed Maurice J (2011) WHO framework targets tuberculosis-diabetes link. Lancet 378(9798):1209–1210CrossRefPubMed
21.
Zurück zum Zitat Kapur A, Harries AD, Lonnroth K, Wilson P, Sulistyowati LS (2016) Diabetes and tuberculosis co-epidemic: the Bali Declaration. Lancet Diabetes Endocrinol 4(1):8–10CrossRefPubMed Kapur A, Harries AD, Lonnroth K, Wilson P, Sulistyowati LS (2016) Diabetes and tuberculosis co-epidemic: the Bali Declaration. Lancet Diabetes Endocrinol 4(1):8–10CrossRefPubMed
22.
Zurück zum Zitat van Crevel R, Dockrell HM, Tandem Consortium (2014) TANDEM: understanding diabetes and tuberculosis. Lancet Diabetes Endocrinol 2(4):270–272CrossRefPubMed van Crevel R, Dockrell HM, Tandem Consortium (2014) TANDEM: understanding diabetes and tuberculosis. Lancet Diabetes Endocrinol 2(4):270–272CrossRefPubMed
23.
Zurück zum Zitat Jeon CY, Harries AD, Baker MA, Hart JE, Kapur A, Lonnroth K et al (2010) Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health 15(11):1300–1314CrossRefPubMed Jeon CY, Harries AD, Baker MA, Hart JE, Kapur A, Lonnroth K et al (2010) Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health 15(11):1300–1314CrossRefPubMed
24.
Zurück zum Zitat Li L, Lin Y, Mi F, Tan S, Liang B, Guo C et al (2012) Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health 17(10):1294–1301CrossRefPubMed Li L, Lin Y, Mi F, Tan S, Liang B, Guo C et al (2012) Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health 17(10):1294–1301CrossRefPubMed
25.
Zurück zum Zitat Castellanos-Joya M, Delgado-Sanchez G, Ferreyra-Reyes L, Cruz-Hervert P, Ferreira-Guerrero E, Ortiz-Solis G et al (2014) Results of the implementation of a pilot model for the bidirectional screening and joint management of patients with pulmonary tuberculosis and diabetes mellitus in Mexico. PLoS ONE 9(9):e106961CrossRefPubMedPubMedCentral Castellanos-Joya M, Delgado-Sanchez G, Ferreyra-Reyes L, Cruz-Hervert P, Ferreira-Guerrero E, Ortiz-Solis G et al (2014) Results of the implementation of a pilot model for the bidirectional screening and joint management of patients with pulmonary tuberculosis and diabetes mellitus in Mexico. PLoS ONE 9(9):e106961CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Prakash BC, Ravish KS, Prabhakar B, Ranganath TS, Naik B, Satyanarayana S et al (2013) Tuberculosis-diabetes mellitus bidirectional screening at a tertiary care centre, South India. Public Health Action 3(Suppl 1):S18–S22CrossRefPubMedPubMedCentral Prakash BC, Ravish KS, Prabhakar B, Ranganath TS, Naik B, Satyanarayana S et al (2013) Tuberculosis-diabetes mellitus bidirectional screening at a tertiary care centre, South India. Public Health Action 3(Suppl 1):S18–S22CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Lin Y, Li L, Mi F, Du J, Dong Y, Li Z et al (2012) Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health 17(10):1302–1308CrossRefPubMed Lin Y, Li L, Mi F, Du J, Dong Y, Li Z et al (2012) Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health 17(10):1302–1308CrossRefPubMed
28.
Zurück zum Zitat Schaberg T, Bauer T, Brinkmann F, Diel R, Feiterna-Sperling C, Haas W et al (2017) S2k-Leitlinie: Tuberkulose im Erwachsenenalter. Pneumologie 71(06):325–397CrossRefPubMed Schaberg T, Bauer T, Brinkmann F, Diel R, Feiterna-Sperling C, Haas W et al (2017) S2k-Leitlinie: Tuberkulose im Erwachsenenalter. Pneumologie 71(06):325–397CrossRefPubMed
29.
Zurück zum Zitat Boillat-Blanco N, Ramaiya KL, Mganga M, Minja LT, Bovet P, Schindler C et al (2016) Transient hyperglycemia in patients with tuberculosis in Tanzania: implications for diabetes screening algorithms. J Infect Dis 213(7):1163–1172CrossRefPubMed Boillat-Blanco N, Ramaiya KL, Mganga M, Minja LT, Bovet P, Schindler C et al (2016) Transient hyperglycemia in patients with tuberculosis in Tanzania: implications for diabetes screening algorithms. J Infect Dis 213(7):1163–1172CrossRefPubMed
30.
Zurück zum Zitat Kumpatla S, Aravindalochanan V, Rajan R, Viswanathan V, Kapur A (2013) Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients – a study from India. Diabetes Res Clin Pract 102(1):60–64CrossRefPubMed Kumpatla S, Aravindalochanan V, Rajan R, Viswanathan V, Kapur A (2013) Evaluation of performance of A1c and FPG tests for screening newly diagnosed diabetes defined by an OGTT among tuberculosis patients – a study from India. Diabetes Res Clin Pract 102(1):60–64CrossRefPubMed
31.
Zurück zum Zitat World Health Organization (2018) Updated and consolidated guidelines for programmatic management. World Health Organization, Geneva World Health Organization (2018) Updated and consolidated guidelines for programmatic management. World Health Organization, Geneva
32.
Zurück zum Zitat Chiang CY, Lee JJ, Chien ST, Enarson DA, Chang YC, Chen YT et al (2014) Glycemic control and radiographic manifestations of tuberculosis in diabetic patients. PLoS ONE 9(4):e93397CrossRefPubMedPubMedCentral Chiang CY, Lee JJ, Chien ST, Enarson DA, Chang YC, Chen YT et al (2014) Glycemic control and radiographic manifestations of tuberculosis in diabetic patients. PLoS ONE 9(4):e93397CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Riza AL, Pearson F, Ugarte-Gil C, Alisjahbana B, van de Vijver S, Panduru NM et al (2014) Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol 2(9):740–753CrossRefPubMedPubMedCentral Riza AL, Pearson F, Ugarte-Gil C, Alisjahbana B, van de Vijver S, Panduru NM et al (2014) Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol 2(9):740–753CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Wang JY, Lee MC, Shu CC, Lee CH, Lee LN, Chao KM et al (2015) Optimal duration of anti-TB treatment in patients with diabetes: nine or six months? Chest 147(2):520–528CrossRefPubMed Wang JY, Lee MC, Shu CC, Lee CH, Lee LN, Chao KM et al (2015) Optimal duration of anti-TB treatment in patients with diabetes: nine or six months? Chest 147(2):520–528CrossRefPubMed
35.
Zurück zum Zitat Critchley JA, Restrepo BI, Ronacher K, Kapur A, Bremer AA, Schlesinger LS et al (2017) Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: part 1: epidemiology and clinical management. Chest 152(1):165–173CrossRefPubMed Critchley JA, Restrepo BI, Ronacher K, Kapur A, Bremer AA, Schlesinger LS et al (2017) Defining a research agenda to address the converging epidemics of tuberculosis and diabetes: part 1: epidemiology and clinical management. Chest 152(1):165–173CrossRefPubMed
36.
Zurück zum Zitat Jørgensen ME, Faurholt-Jepsen D (2014) Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review. Curr Diab Rep 14(7):505CrossRefPubMed Jørgensen ME, Faurholt-Jepsen D (2014) Is there an effect of glucose lowering treatment on incidence and prognosis of tuberculosis? A systematic review. Curr Diab Rep 14(7):505CrossRefPubMed
37.
Zurück zum Zitat Hossain MD, Ahmed JU, Rahim MA, Musa AKM, Latif ZA (2016) Bangladesh national guidelines on the management of tuberculosis and diabetes mellitus co-morbidity (summary). Indian J Endocrinol Metab 20(6):853–857CrossRefPubMedPubMedCentral Hossain MD, Ahmed JU, Rahim MA, Musa AKM, Latif ZA (2016) Bangladesh national guidelines on the management of tuberculosis and diabetes mellitus co-morbidity (summary). Indian J Endocrinol Metab 20(6):853–857CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Tornio A, Niemi M, Neuvonen PJ, Backman JT (2012) Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications. Trends Pharmacol Sci 33(6):312–322CrossRefPubMed Tornio A, Niemi M, Neuvonen PJ, Backman JT (2012) Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications. Trends Pharmacol Sci 33(6):312–322CrossRefPubMed
Metadaten
Titel
Diabetes und Tuberkulose
Eine kurze Übersicht
verfasst von
Dr. B. Lange
A. Bockey
J. L. Z. Nyirenda
D. Wagner
Publikationsdatum
02.05.2018
Verlag
Springer Medizin
Erschienen in
Die Diabetologie / Ausgabe 3/2018
Print ISSN: 2731-7447
Elektronische ISSN: 2731-7455
DOI
https://doi.org/10.1007/s11428-018-0327-x

Weitere Artikel der Ausgabe 3/2018

Der Diabetologe 3/2018 Zur Ausgabe

Mitteilungen des BDI

Mitteilungen des BDI

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.